# q08 rev 0 raw returns (tested_sha256 b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5)

Fresh agents dispatched 2026-10-06 by the caller (Claude Code, Opus 5.5) with only the workspace
root, their own packet path and the verbatim question (closed-book: question only). Returns are
copied verbatim from the task notifications.

## Blind solver A (blind-solver, packet solver-1)

answer: −$0.10. The low end of the range fell from $5.55 to $5.45.

confidence: high

path:
1. **Completion date.** D08 line 27 says: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences". D08 line 137 and D10 line 203 say the same: "On March 23, 2026, Abbott completed the acquisition of Exact Sciences."
2. **Guidance on March 23, 2026.** The latest guidance before that date is D07 (Jan. 22, 2026), lines 31 and 335: "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80". No packet document dated between Jan. 22 and Apr. 16, 2026 changes it. D08's headline (line 15) supports that the next update came after closing: "Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences". That update is dated April 16, 2026, and set the range at "$5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences" (D08 line 223). D07 line 33 also said the deal was then still expected "to close in the second quarter of 2026". **Low end on completion day: $5.55.**
3. **The June 2026 dividend.** D10 line 337: "On June 12, 2026, the board of directors of Abbott declared the company's quarterly dividend of $0.63 per share. Abbott's cash dividend is payable Aug. 17, 2026". I treated the payable date as the payment day.
4. **Guidance on Aug. 17, 2026.** D10 (July 16, 2026), lines 29 and 329: "Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58". The only later packet document, D11 (Aug. 20, 2026), is a litigation settlement release. It has no guidance and is dated after Aug. 17. **Low end on payment day: $5.45.**
5. **Calculation.** $5.45 − $5.55 = −$0.10. Step by step, the low end went 5.55 → 5.38 (−0.17), then → 5.45 (+0.07), for a net change of −0.10.
6. **Source check.** The key figures appear in the original docs/ files the expected number of times: 3 in abt_ex991_2026-01-22.txt, 2 in abt_ex991_2026-04-16.txt and 5 in abt_ex991_2026-07-16.txt. This matches the text extractions.

minimal_documents: D07 and D10. D07 gives the range in effect on March 23. D10 gives the completion date (line 203), the June 12 declaration with the Aug. 17 payable date, and the $5.45–$5.60 range. D08 backs up the completion date and confirms the first guidance update after closing was April 16. It can replace D10 for the completion date only. No other document can replace D07 or the dividend and guidance facts in D10.

readings:
- **Main reading:** compare the guidance in effect on each of the two days. Answer: −$0.10.
- **Alternative:** treat the first guidance that reflected the acquisition (April 16: $5.38 low end) as the completion-day figure. Answer: $5.45 − $5.38 = +$0.07. This is weaker, because that range was issued 24 days after closing and was not in effect on March 23.

gaps:
- The packet has no document dated between Jan. 22 and Apr. 16, 2026, or between Jul. 16 and Aug. 17, 2026. "No intervening guidance change" therefore rests on the packet's coverage plus D08's "Updates Guidance" headline. An unpacketed release (for example, on the closing day) can't be ruled out.
- The payment date is the stated "payable" date, not a confirmation that the dividend was paid.
- What I read: all of D07, D09 and D11 that mattered, D08 lines 1–60 and 215–239, and D10 lines 1–50 and 320–344, plus targeted searches across D01–D11. D05 and D06 were only searched (EPS, guidance, dilution and 2026 terms) and contain no 2026 EPS guidance. D01–D04 were only searched; they contain 2025 guidance only.
- No extraction problems. All sources are text, with no PDFs or layout files.

contaminated: no

Relevant files:
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r0-v2-b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5\solver-1\text\D07.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r0-v2-b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5\solver-1\text\D08.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r0-v2-b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5\solver-1\text\D10.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r0-v2-b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5\solver-1\text\D11.txt

## Blind solver B (blind-solver, packet solver-2)

**answer:** −$0.10. The low end fell from $5.55 to $5.45.

**confidence:** high

**path:**
1. **Acquisition completion date.** D08 (dated April 16, 2026), line 27: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences." D10, lines 49 and 685, gives the same date.
2. **Guidance in effect on March 23, 2026.** D07 (dated Jan. 22, 2026), lines 31 and 335: "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80." The next change in the packet is D08 on April 16, 2026, which is after the closing. Its headline (line 15) reads "Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences" and it sets "$5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences" (lines 19, 31, 223). No packet document dated between Jan. 22 and April 16, 2026 gives a different range. So the low end on March 23 was **$5.55**.
3. **Dividend declared in June 2026 and its payment day.** D10 (dated July 16, 2026), line 337: "On June 12, 2026, the board of directors of Abbott declared the company's quarterly dividend of $0.63 per share. Abbott's cash dividend is payable Aug. 17, 2026, to shareholders of record at the close of business on July 15, 2026." The payment day is therefore **Aug. 17, 2026**.
4. **Guidance in effect on Aug. 17, 2026.** D10, line 29: "Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58." Line 329 repeats $5.45 to $5.60. The only later document, D11 (Aug. 20, 2026, a settlement of infant-formula lawsuits), comes after Aug. 17 and has no guidance. So the low end on Aug. 17 was **$5.45**.
5. **Calculation.** $5.45 − $5.55 = **−$0.10**. The route in between was $5.55 → $5.38 (−$0.17 on April 16), then $5.38 → $5.45 (+$0.07 on July 16). The net is −$0.10.

**minimal_documents:** D07, D08, D10.
- D07 is the only source for $5.55.
- D10 is the only source for the June 12 declaration, the Aug. 17 payable date and the $5.45 range.
- D08 shows that the $5.38–$5.58 range only appeared on April 16, after the closing. Without it, D10's "previous range" could have been issued on March 23.
- The acquisition date appears in both D08 and D10.

No other packet document could replace any of these.

**readings:**
- If "guidance on the completion day" means the first range that reflected the acquisition ($5.38, issued April 16), the answer would be +$0.07. That range didn't exist on March 23, so this reading is weaker.
- Using a different dividend gives different answers, but neither matches the question. The Feb. 20, 2026 declaration (payable May 15, 2026) would give $5.38, or −$0.17. The June 13, 2025 declaration (D03) is the wrong year.

**gaps:**
- The packet says the dividend was "payable" on Aug. 17, 2026; nothing confirms it was actually paid that day. I treated the payable date as the payment day.
- The packet has no documents from Jan. 23 to April 15, 2026 or from July 17 to Aug. 19, 2026, so a guidance change outside the packet in those windows can't be ruled out. D08 calling its April 16 release the guidance update for the acquisition argues against one.
- Coverage:
  - Read in full: D09 (Apr. 17, 2026 notice of a derivative-suit settlement) and D11.
  - Read in part: D07 (lines 1–120 and 325–354), D08 (lines 1–60 and 200–279), D10 (lines 1–60 and 318–342), D05 (lines 13–57).
  - Searched all texts for "Exact Sciences", "dividend" and the guidance figures. Searched D05 and D06 for EPS, dilution and guidance terms; neither has any 2026 EPS guidance.
  - D01–D04 (2025 earnings releases) were only searched, not read.
- All sources were extracted as plain text with no PDF pages, so there were no extraction problems. I didn't open the packet's question.txt.

**contaminated:** no

Key paths:
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r0-v2-b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5\solver-2\text\D07.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r0-v2-b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5\solver-2\text\D08.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r0-v2-b25a25315d08abd6031aa8bfea024321fdb38412575408445cb230e4535c47f5\solver-2\text\D10.txt

## Closed-book solver (question only, no tools used)

answer: −$0.17 (estimate)
confidence: low
basis: I'm fairly sure that in January 2026 Abbott guided full-year 2026 adjusted diluted EPS to $5.55–$5.80, excluding Exact Sciences. I think the deal closed around March 2026, so the low end on the closing day would have been $5.55. I also faintly remember an update after closing that cut the range to about $5.38–$5.58 to account for Exact Sciences' drag on earnings. That gives −$0.17, but the memory may be wrong. The dividend declared in June 2026 would normally be paid on August 15, 2026. The Q2 results around July 2026 could have narrowed the range and lifted the low end, and they are past my June 2026 knowledge cutoff, so I can't confirm the guidance in force that day.
contaminated: no

## Shortcut auditor (shortcut-auditor, packet shortcut)

answer: −$0.10. The low end fell from $5.55 to $5.45.

verdict: clear

shortest_path:
1. **Acquisition date.** D08 (Apr. 16, 2026), line 27: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences." D10 repeats this at lines 49, 203 and 685.
2. **Guidance on March 23, 2026.** The only 2026 guidance issued by then is D07 (Jan. 22, 2026), lines 31 and 335: "full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80". The next range comes from D08, dated April 16, after the closing. Its headline reads "Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences" and gives "$5.38 to $5.58, which includes $0.20 of dilution related to the acquisition" (lines 15, 19, 223). So the low end on March 23 was $5.55.
3. **Dividend payment date.** D10 (Jul. 16, 2026), line 337: "On June 12, 2026, the board of directors of Abbott declared the company's quarterly dividend of $0.63 per share. Abbott's cash dividend is payable Aug. 17, 2026."
4. **Guidance on Aug. 17, 2026.** D10, lines 29 and 329: "raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60". The only later document is D11 (Aug. 20), a release about settling preterm infant formula lawsuits. It has no guidance and is dated after Aug. 17 anyway. So the low end on Aug. 17 was $5.45.
5. **Calculation.** $5.45 − $5.55 = −$0.10.

sufficient_documents: D07, D08 and D10 are the minimal set I verified.
- D07 supplies the $5.55 range in effect on March 23.
- D10 supplies the June 12 declaration, the Aug. 17 payment date and the $5.45 range.
- D08 is needed to show that the intermediate $5.38–$5.58 range was issued after the closing (April 16), not on or before March 23. D10 mentions that "previous range" but does not date it.
- The closing date can come from either D08 or D10.
- No single document holds both $5.55 and $5.45.

searches:
- Terms searched across all text files:
  - "Exact Sciences"
  - "dividend"
  - "adjusted diluted (EPS|earnings)", "guidance", "projects full-year"
  - "$5.xx" amounts
  - "previous", "prior range", "reaffirm", "outlook", "forecast"
  - "dilut", "accreti", "EPS", "2026"
- Read the guidance and dividend sections of D07, D08 and D10. Read D09 and D11 in full.
- D09 (Apr. 17, 2026) is a notice of a proposed settlement of a shareholder derivative lawsuit, with no guidance.
- D06 (Dec. 12, 2025) is the amended bylaws, with no EPS or 2026 references.
- D05 (Nov. 20, 2025) announces the acquisition deal, with no EPS dilution figures.
- D01–D04 are 2025 releases covering FY2025 guidance only.
- I checked the key figures and dates against the original docs/ files, and they match the text extraction exactly.
- I did not open question.txt or any notes, other packets or outside material.

readings/gaps:
- **Trap reading (+$0.07).** D10's own comparison ("$5.45 to $5.60, compared to previous range of $5.38 to $5.58") gives 5.45 − 5.38 = +$0.07. That treats the post-closing April 16 range as the one in effect on the closing day, which is wrong on dates: it was issued 24 days after March 23. This is a trap, not a valid shortcut.
- **Other variants.** Comparing midpoints or high ends answers a different question than the one asked.
- **Gaps.** The packet has no documents between Jan. 22 and Apr. 16, 2026, or between Jul. 16 and Aug. 17, 2026. If Abbott had changed guidance on the closing day in a filing outside the packet, the packet couldn't show it. D08's "Updates Guidance to Reflect Acquisition" headline points to April 16 as the first post-closing update. I found no extraction problems.
- **Difficulty risk.** The correct route is a simple join of three documents plus a one-step subtraction. The main difficulty is the date logic needed to avoid D10's answer-shaped "previous range" comparison.
